__timestamp | Supernus Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 5758000 | 60987000 |
Thursday, January 1, 2015 | 8423000 | 125542000 |
Friday, January 1, 2016 | 11986000 | 210460000 |
Sunday, January 1, 2017 | 15215000 | 275119000 |
Monday, January 1, 2018 | 15356000 | 409539000 |
Tuesday, January 1, 2019 | 16660000 | 547758000 |
Wednesday, January 1, 2020 | 52459000 | 736300000 |
Friday, January 1, 2021 | 75061000 | 904200000 |
Saturday, January 1, 2022 | 87221000 | 1080300000 |
Sunday, January 1, 2023 | 83779000 | 1262200000 |
Monday, January 1, 2024 | 1530500000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. have showcased contrasting trajectories in their cost of revenue. From 2014 to 2023, Vertex's cost of revenue surged by over 1,900%, reflecting its aggressive expansion and investment in cutting-edge treatments. In contrast, Supernus Pharmaceuticals experienced a more modest increase of approximately 1,350%, indicating a steady growth strategy.
These trends underscore the diverse strategies employed by pharmaceutical companies to navigate the ever-evolving healthcare landscape.
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Viatris Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Supernus Pharmaceuticals, Inc.'s Expenses
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.